Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 79,949 shares at $115.02 ($9.6M) on 2017-08-08, disclosed to the SEC on 2017-08-10.
Open-market sale of $9.6M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.02 | 11,074 | $1.3M | 13.3% |
| 2 | $117.27 | 1,700 | $199K | 2.1% |
| 3 | $118.61 | 3,800 | $451K | 4.7% |
| 4 | $119.94 | 18,936 | $2.3M | 23.8% |
| 5 | $120.40 | 31,165 | $3.8M | 39.3% |
| 6 | $121.37 | 13,274 |
| $1.6M |
| 16.9% |
| Total | $119.56 avg | 79,949 | $9.6M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |